Epidemiology of childhood invasive pneumococcal disease in Australia: a prospective cohort study

Linny Kimly Phuong1,2, Abigail Cheung3, Tiarni Templeton4

  • 1Antimicrobials Group, Murdoch Children's Research Institute, Parkville, Victoria, Australia linny.phuong@mcri.edu.au.

PubMed

Insights

Pneumococcal conjugate vaccines (PCV) have altered invasive pneumococcal disease (IPD) in children. Complicated pneumonia remains common, while non-vaccine serotypes (NVTs) dominate serious IPD cases, necessitating treatment guideline updates.

Area of Science:

  • Pediatric Infectious Diseases
  • Vaccinology
  • Epidemiology

Background:

  • Widespread use of pneumococcal conjugate vaccines (PCV) has significantly impacted the epidemiology of invasive pneumococcal disease (IPD) in children globally.
  • Despite vaccination, IPD remains a concern in pediatric populations.

Purpose of the Study:

  • To analyze current trends in IPD presentations, serotypes, and antimicrobial resistance in Australian children.
  • To inform clinical management and public health strategies for IPD.

Main Methods:

  • A multicentre prospective audit of IPD episodes in children (<18 years) across five Australian pediatric hospitals.
  • Data collected over 5.5 years (2016-2021) for children with *Streptococcus pneumoniae* isolated from sterile sites.

Main Results:

  • 377 IPD episodes occurred in 375 children; 90% had received ≥3 PCV doses.
  • Complicated pneumonia was the most frequent presentation (67%), followed by bacteraemia (17%) and meningitis (8%).
  • Non-vaccine serotypes (NVTs) predominated in bacteraemia and meningitis, and high ceftriaxone resistance (17%) was observed in NVT 23B isolates, particularly in meningitis cases (22%).

Conclusions:

  • Complicated pneumonia is the leading IPD manifestation in vaccinated children.
  • NVTs are increasingly responsible for severe IPD, including meningitis and bacteraemia.
  • High ceftriaxone resistance in NVT 23B suggests vancomycin should be considered for empiric meningitis treatment.
Abstract

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
214
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
1.9K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
182
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.5K